mortality/aging
• within 10 to 11 days of tamoxifen-induction
|
digestive/alimentary system
• following tamoxifen-induction, mice exhibit widespread mucosal epithelial degeneration more so in the small and large intestines and less in the stomach compared with control mice
• however, mice do not exhibit a distended intestine morphology
|
• focal atypical hyperplasia of mucosal crypts with small clusters of enlarged atypical crypts lined by tall dysplastic basophilic epithelial cells in the small intestine following tamoxifen-induction
|
• following tamoxifen-induction, mice exhibit swollen and basophilic surface epithelial cells in the large intestine compared with control mice
|
• loss of mucosal crypts in some areas of the large intestine following tamoxifen-induction
|
• following tamoxifen-induction, mice exhibit swollen villous epithelial cells with excessive vacuoles in the small intestine compared with control mice
|
• following tamoxifen-induction, mice exhibit loose or discolored intestine content
|
growth/size/body
• thin following tamoxifen-treatment
|
behavior/neurological
• in moribund mice following tamoxifen-induction
|
• following tamoxifen-treatment
|
integument
• poor coat condition following tamoxifen-treatment
|
endocrine/exocrine glands
• loss of mucosal crypts in some areas of the large intestine following tamoxifen-induction
|
• focal atypical hyperplasia of mucosal crypts with small clusters of enlarged atypical crypts lined by tall dysplastic basophilic epithelial cells in the small intestine following tamoxifen-induction
|